Literature DB >> 8527547

Clinical features and outcome of severe malaria in Gambian children.

D Waller1, S Krishna, J Crawley, K Miller, F Nosten, D Chapman, F O ter Kuile, C Craddock, C Berry, P A Holloway.   

Abstract

The clinical and laboratory features of severe falciparum malaria in 180 Gambian children were studied between 1985 and 1989. Of the 180 children, 118 (66%) presented with seizures, 77 (43%) had cerebral malaria, 35 (20%) had witnessed seizures after admission, 29 (16%) were hypoglycemic, and 27 (15%) died. Respiratory distress was a common harbinger of a fatal outcome. The differences in admission parasite counts in the blood, hematocrit, and opening cerebrospinal pressures for patients who died and survivors were not significant. A multiple logistic regression model identified neurological status (coma, particularly if associated with extensor posturing), stage of parasite development on the peripheral blood film, pulse rate of > 150 or respiratory rate of > 50, hypoglycemia, and hyperlactatemia (plasma lactate level, > 5 mmol/L) as independent indicators of a fatal outcome. Biochemical evidence of hepatic and renal dysfunction was an additional marker of a poor prognosis, but, in contrast to severe malaria in adults, none of these children with severe malaria had acute renal failure.

Entities:  

Mesh:

Year:  1995        PMID: 8527547     DOI: 10.1093/clinids/21.3.577

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  64 in total

1.  Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description.

Authors:  J Makani; W Matuja; E Liyombo; R W Snow; K Marsh; D A Warrell
Journal:  QJM       Date:  2003-05

2.  Population pharmacokinetics of intramuscular quinine in children with severe malaria.

Authors:  S Krishna; N V Nagaraja; T Planche; T Agbenyega; G Bedo-Addo; D Ansong; A Owusu-Ofori; A L Shroads; G Henderson; A Hutson; H Derendorf; P W Stacpoole
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  The role of lumbar puncture in suspected CNS infection--a disappearing skill?

Authors:  R Kneen; T Solomon; R Appleton
Journal:  Arch Dis Child       Date:  2002-09       Impact factor: 3.791

4.  Impairment of functional capillary density but not oxygen delivery in the hamster window chamber during severe experimental malaria.

Authors:  Judith Martini; Irene Gramaglia; Marcos Intaglietta; Henri C van der Heyde
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 5.  Malaria-induced renal damage: facts and myths.

Authors:  Jochen H H Ehrich; Felicia U Eke
Journal:  Pediatr Nephrol       Date:  2007-01-05       Impact factor: 3.714

6.  Burden of cerebral malaria in central India (2004-2007).

Authors:  Vidhan Jain; Avinash C Nagpal; Pradeep K Joel; Manmohan Shukla; Mrigendra P Singh; Rasik B Gupta; Aditya P Dash; Saroj K Mishra; Venkatachalam Udhayakumar; Jonathan K Stiles; Neeru Singh
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

Review 7.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

8.  In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.

Authors:  Johanna P Daily; Karine G Le Roch; Ousmane Sarr; Daouda Ndiaye; Amanda Lukens; Yingyao Zhou; Omar Ndir; Soulyemane Mboup; Ali Sultan; Elizabeth A Winzeler; Dyann F Wirth
Journal:  J Infect Dis       Date:  2005-02-28       Impact factor: 5.226

9.  Malaria and acute kidney injury.

Authors:  Denver D Brown; Sonia Solomon; Daniele Lerner; Marcela Del Rio
Journal:  Pediatr Nephrol       Date:  2019-01-31       Impact factor: 3.714

Review 10.  Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.

Authors:  Vasee S Moorthy; Zarifah Reed; Peter G Smith
Journal:  Malar J       Date:  2009-02-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.